Clinical trial No longer in our active list Interventional Ages 18 and up

Evaluating a new minimally invasive surgery for glaucoma

Official title: Efficacy and Safety of Minimally Invasive Micro-Sclerostomy (MIMS) in Glaucoma Surgery

Run by Hôpital Privé de la Baie · NCT06213805 · Data updated 2026-05-14

This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.

This study is testing a new, less invasive surgery for glaucoma to see if it leads to fewer complications and a quicker recovery compared to traditional surgery.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment23 (estimated)
SponsorHôpital Privé de la Baie
Academic / other
Locations3 sites (Avranches and 2 other locations)
Trial IDNCT06213805 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults aged 18 and older with specific types of glaucoma who have not achieved adequate control of their condition through medication.

Probably not a fit

Patients with other significant eye conditions or those who have had previous intraocular surgeries may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to assess the effectiveness and safety of a minimally invasive microsclerostomy (MIMS) procedure in patients requiring glaucoma surgery. It compares the outcomes of MIMS with traditional surgical methods, focusing on the incidence of complications and overall patient recovery. The ophthalmologist will monitor participants and gather clinical data to evaluate the benefits of this innovative approach. Patients are expected to experience fewer complications than those undergoing conventional surgery.

Why it matters

Potential benefit: If successful, this procedure could lead to safer and more effective treatment options for patients with glaucoma.

How similar studies have gone: While this approach is innovative, similar minimally invasive techniques have shown promise in other studies, suggesting potential for success.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients ≥ 18 years old who agree to participate in the study having signed informed consent
* Primary open-angle glaucoma, pseudoexfoliative glaucoma or pigmentary glaucoma with indication for glaucoma surgery (defined as uncontrolled intraocular pressure or worsening of visual fields, despite maximum tolerated medical therapy) and open iridocorneal angle ( trabecular meshwork visible on gonioscopy, Shaffer classification grade 3-4) and healthy and mobile conjunctiva (without scars or adhesions).
* Chronic angle closure glaucoma with indication for combined glaucoma and cataract surgery

Exclusion Criteria:

* Presence of other ophthalmological pathologies (except cataract)
* History of intraocular surgery (unless cataract surgery), history of trauma, or conjunctival scarring in the quadrant planned for surgery
* Visual acuity lower than "counts fingers" ", closure of the iridocorneal angle (and angle-closure glaucoma unless associated cataract surgery), neovascular glaucoma or neovascularization of the iris, pachymetry \< 490 μm or \> 620 μm.
* Presence of severe systemic pathologies, pregnant or breastfeeding woman

Where it's running

  • Hôpital Privé de la Baie
    Avranches, France
    Recruiting
  • Clinique Thiers
    Bordeaux, France
    Active not recruiting
  • Fondation Rothschild
    Paris, France
    Active not recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.